Fig. 2From: Toll-like receptor 2 and type 2 diabetesFollowing TLR2-ligand interaction a signaling pathway is started using MYD88 as an adaptor molecule. The signaling pathway leads to the activation of several transcription factors, including NF-kB, MAPK and AP-1, and subsequently cell activation. Adapted from Bagheri et al. [29]Back to article page